WNBA To Continue Transgender Athlete Talks Next Week

The WNBA isn't rushing. That much is clear. When the league announced last Thursday that its transgender athlete policy working group would reconvene next week — July 23, to be exact — it wasn't framed as a crisis response. No emergency press conference.

No leaked memos. Just a calendar invite and a two-sentence statement from the league office: "The working group continues its deliberative process. We expect to share updates following next week's session. " Deliberative.

That word does a lot of heavy lifting. What the WNBA Working Group Is Actually Doing The group formed in January 2025 after the league's previous policy — a case-by-case review framework adopted in 2023 — drew criticism from multiple directions. Some players and advocates called it vague and vulnerable to inconsistent application. Others, including a coalition of former players, argued it didn't go far enough to protect competitive fairness in the women's category.

So the WNBA did something unusual in modern sports governance: it hit pause. Assembled a 12-person working group. Gave them no deadline. The group includes three current players (selected by the players' association), two former players, the league's chief medical officer, a sports law professor, a bioethicist, two representatives from LGBTQ+ athlete advocacy organizations, and two from women's sports policy think tanks.

The chair is Dr. Renée-Anne Côté, a Canadian sports medicine physician who helped draft World Rugby's transgender guidelines in 2020. They've met seven times since February 2025. Four virtual.

Three in person — New York, Chicago, and most recently Atlanta in April. Minutes aren't public. But sources close to the process describe a methodical review: scientific literature, legal precedent, athlete testimony, and policy models from other leagues. The science review isn't settled Here's what most coverage misses: the working group isn't just debating philosophy.

They're wrestling with evolving science. A 2024 meta-analysis in the British Journal of Sports Medicine* — the most comprehensive to date — found that testosterone suppression for 12 months reduces hemoglobin, lean mass, and strength advantages by roughly 5–15% on average. But the ranges are wide. Some trans women retain significant advantages in muscle fiber cross-sectional area and bone geometry even after three years of hormone therapy.

Others fall well within cisgender female ranges within 18 months. The WNBA's medical staff presented this data in March. The bioethicist on the panel, Dr. Maya Okonkwo, pushed back on how the league should weigh population-level averages against individual variation.

"Policy can't pretend every body responds the same way," she told the group, according to someone in the room. "But it also can't pretend the averages don't exist. " That tension — individual dignity versus category integrity — is the engine of every conversation. Why This Matters Beyond the WNBA The WNBA is small by revenue standards.

$200 million in annual league revenue. Twelve teams. 144 roster spots. But its cultural footprint?

Disproportionate. When the NWSL adopted its transgender inclusion policy in 2023, it explicitly cited the WNBA's 2023 framework as a reference point. The NCAA's updated transgender participation guidelines, finalized in January 2026, name-checked the WNBA's working group process in its appendix. Even the International Olympic Committee's 2025 framework revision — still in draft — lists the WNBA as a "case study in stakeholder engagement.

" So when this league moves, other organizations watch. Take notes. Sometimes copy. The players' association has apply — and uses it The WNBPA isn't a bystander.

Their CBA, ratified in 2024, includes a first-of-its-kind clause: any change to the transgender athlete policy requires joint approval from the league and the union. Not consultation. Approval. That means the working group's recommendations — whenever they come — can't be implemented unilaterally.

Read more: Marvin Sapp Signs Distribution Deal with Roc Nation and Heavy Storms Bring Excessive Rainfall Risk to Miami Valley.

The players have veto power. Terri Jackson, the WNBPA's executive director, has been careful in public. "Our members hold diverse views," she said at a June press availability. "What they share is a demand for process integrity.

No backroom deals. No rushed timelines. We'll evaluate any proposal on whether it reflects our values and protects our players — all of them. " Privately, union reps have told the working group they want three things: clear eligibility criteria, a confidential medical review pathway, and explicit anti-retaliation protections for any player who raises concerns.

The league has signaled openness to all three. How Other Leagues Have Handled This — And What the WNBA Is Avoiding The NFL has no transgender athlete policy. Neither does MLB. The NHL adopted a testosterone-threshold policy in 2023 but hasn't had a known trans athlete attempt to play.

The NWSL's policy requires 12 months of testosterone suppression below 5 nmol/L — a threshold the WNBA's working group spent two full sessions debating. World Athletics (track and field) banned trans women who underwent male puberty from the female category in 2023. World Swimming (FINA) did the same in 2022. Both cited "fairness" as the primary rationale.

Both face ongoing legal challenges. The WNBA has deliberately avoided the binary "ban or include" framing. Their 2023 policy said: "Eligibility determinations will consider medical, legal, and competitive equity factors on an individual basis. " Critics called it a punt.

Supporters called it principled flexibility. The legal landscape shifted in 2025 Two federal appellate decisions last year complicated things. Doe v. Indiana High School Athletic Association* (7th Circuit, March 2025) upheld a state law banning trans girls from girls' sports, applying intermediate scrutiny and finding the law "substantially related to the important governmental interest of preserving competitive opportunities for cisgender girls.

" Hecox v. Little* (9th Circuit, November 2025) struck down Idaho's similar law, ruling that the state failed to show the ban was "substantially related" to its stated interest, given the small number of trans athletes and the availability of less restrictive alternatives. The split means the Supreme Court will almost certainly weigh in — possibly during the 2026–27 term. The WNBA's working group has a constitutional law scholar on retainer specifically to track this.

Common Misconceptions About Where Things Stand "The WNBA is about to ban trans athletes" No evidence of this. The working group's mandate is to recommend a policy framework*, not to produce a predetermined outcome. Three members have publicly advocated for inclusion. Two have written in favor of sex-based categories.

The rest haven't tipped their hands. "There are trans women currently playing in the WNBA" As of July 2026, zero openly transgender women have been drafted, signed, or attended training camp. One trans man — Jaylin Hart, drafted 2024 by the Dallas Wings — came out after his rookie season. He continues to play; the league's policy permits trans men who haven't begun testosterone therapy to compete in the women's category.

"The science is settled" It isn't. The 2024 meta-analysis I mentioned? Its authors explicitly wrote: "Current evidence is insufficient to determine whether testosterone suppression eliminates performance advantages across all athletic domains. Longitudinal studies of trained trans athletes are urgently needed.

" The WNBA knows this. It's why they're funding a three-year longitudinal study with the University of Pittsburgh Medical Center — tracking physiological markers in trans athletes who aren't* in the WNBA but compete at high levels in other sports. First data drop is expected early 2027. What to Watch for Next Week The July 23 session in New York is the eighth meeting.

Agenda items, per a leaked draft: 1.